The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
Open accessAbstract
PURPOSE OF REVIEW: In this review, we highlight the most important cellular and molecular mechanisms that contribute to cardiac inflammation and fibrosis. We also discuss the interplay between inflammation and fibrosis in various precursors of heart failure (HF) and how such mechanisms can contribute to myocardial tissue remodelling and development of HF. RECENT FINDINGS: Recently, many research articles attempt to elucidate different aspects of the interplay between inflammation and fibrosis. Cardiac inflammation and fibrosis are major pathophysiological mechanisms operating in the failing heart, regardless of HF aetiology. Currently, novel therapeutic options are available or are being developed to treat HF and these are discussed in this review. A progressive disease needs an aggressive management; however, existing therapies against HF are insufficient. There is a dynamic interplay between inflammation and fibrosis in various precursors of HF such as myocardial infarction (MI), myocarditis and hypertension, and also in HF itself. There is an urgent need to identify novel therapeutic targets and develop advanced therapeutic strategies to combat the syndrome of HF. Understanding and describing the elements of the inflammatory and fibrotic pathways are essential, and specific drugs that target these pathways need to be evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 A simplified depiction of sequence of events in an inflammatory response and the role of proresolution mediators in its termination. Tissue injury elicits an initial vascular response, followed by an influx of neutrophils and monocytes to the damaged area. After reaching the tissue, monocytes transform into macrophages and actively phagocytose the debris. Lymphocytes, which are cells of the adaptive immune system, later modulate this initial response. The basic mechanisms of resolution of inflammation are highlighted which are (1) lipid mediator class switching producing proresolution molecules such as lipoxins and resolvins; (2) increased efferocytosis by macrophages; (3) anti-inflammatory cytokines secreted by “resolving” macrophages and regulatory T cells. Failure to resolve leads to persistence of inflammation resulting in a chronic inflammatory state, causing sustained tissue injury. Adapted figure reproduced from [17] Buckley et al. 2014 with permission from the authors. PGE2, prostaglandin E2; PGI2, prostacyclin](https://figures.cochat.ai/paper-figures/8fe93a233d6341cc866ef47ebf2b0c3d/from-inflammation-to-fibrosismolecular-and-cellular-mechanisms-of-myocardial-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, extensive cardiac fibrosis causes electro-mechanical disturbances in the heart and decreases the cardiac contractile reserve, which results in an attenuated ability of the heart to maintain cellular perfusion under normal cardiac filling pressure, eventually leading to HF [46].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“…for instance, cytokines secreted from Th1 cells sustain inflammation while Th2 cytokines produce anti-inflammatory and prohealing signals [38]. b. Pro-inflammatory cardiomyocytes in cardiac injury: Cardiomyocytes (~30 – 40% of cells in the healthy heart) secrete pro-inflammatory…”
BackgroundA Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 1×
“It is hypothesised that the presence of co-morbidities might lead to increased inflammation and to HF [130 (cid:129) ].”
BackgroundMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 2×
“Leukocytes are major cellular effectors that direct this response through various mechanisms, including chemical mediators such as cytokines [7].”
BackgroundFadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 1×
“The phagocytosed particle can influence phenotypic characteristics of macrophages [24, 25]; for instance, macrophages assume a more fibrotic (M2) phenotype after ingesting apoptotic neutrophils [26].”
BackgroundTakeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Epidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077 · cited 14×
“For instance, reduction of myocardial inflammation in the initial phases of MI or during the early phases of ischaemia-reperfusion injury could potentially yield better outcomes [91•]. However, premature attenuation of fibrosis, e.g. during the onset of the proliferative phase, could result in cardiac rupture or aneur…”
BackgroundMethodInfluential
Cited by
Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation
Marinho, A., Nunes, C., & Reis, S. (2021) · Biomolecules · doi:10.3390/biom11101518 · Cited by 460
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
“IL-33 ST2 & IL-1RAP Alarmin/DAMP (303) TNF⍺ TNFR1 or TNFR2 Early inflammatory marker and i IFNɣ IFNɣR1/2 Macrophage polarization and fac presentation (306, 307) MCP-1/CCL2 CCR2 Immune cell recruitment (306) MIP-1⍺/CCL3 CCR1/5 Immune cell recruitment (309) G-CSF G-CSFR Hematopoiesis (17) CXCL1 CXCR2 Immune cell recruit…”
BackgroundFibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J. L., Naves-Díaz, M., Carrillo-López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 372
“After cardiac damage, the release and increase of IL-10, insulin growth factor 1 (IGF1), TGF-β1, and Galectin-3 by modified macrophages induces ECM remodeling [36,37].”
Backgroundde Boer, R. A., De Keulenaer, G., Bauersachs, J., Brutsaert, D., Cleland, J. G., Diez, J., Du, X.-J., Ford, P., Heinzel, F. R., Lipson, K. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1406 · Cited by 304
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
Mitrani, R. D., Dabas, N., & Goldberger, J. J. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.06.026 · Cited by 302
“In patients with COVID-19, it is plausible that myocardial involvement can be the initiator of a pathway of inflammation and subsequent fibrosis.(8) If the extent and distribution of fibrosis produces electrophysiological abnormalities that predispose to atrial fibrillation and ventricular arrhythmias, early detection…”
Metadata
- Authors
- Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A.
- Affiliations
- University Medical Center Groningen (NL)
- Venue
- Current Heart Failure Reports
- Published
- 2017-07-13
- Volume
- 14
- Issue
- 4
- Pages
- 235-250
- ISSN
- 1546-9530 (ISSN-L)
- 1546-9549
- PMC
- PMC5527069
- OpenAlex
- W2735815044
- Cited by
- 307
- References
- 155
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 35 · 2023: 34 · 2022: 30 · 2021: 54 · 2020: 57 · 2019: 27 · 2018: 24 · 2017: 2
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Current Heart Failure Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- University of Groningen
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- cardiac inflammation, myocardial fibrosis, myocardial remodelling, heart failure, myocardial infarction, myocarditis, hypertension, therapeutic target, heart failure treatment
- MeSH terms
- Fibrosis, Heart Failure, Humans, Hypertension, Myocardial Infarction, Myocarditis, Myocardium, Ventricular Remodeling, Atrial Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. https://app.cochat.ai/papers/10.1007/s11897-017-0343-y
- The paper
- Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017). From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Current Heart Failure Reports. https://doi.org/10.1007/s11897-017-0343-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.